Skip to content

Clinical trials

Completed Phase 2 Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 2 Status: Completed Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20033
20047
20055
20066
20076
20088
20097
20102
20114
20125
20132
20145
20156
20161
20181
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital6
Amgen5
Eli Lilly and Company4
National Center for Complementary and Integrative Health (NCCIH)4
Northwestern University4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Merck Sharp & Dohme LLC3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Creighton University2
Elizabeth Shane2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis99
Bone Diseases, Metabolic26
Osteoporosis, Postmenopausal12
Bone Diseases9
Fractures, Bone6
Musculoskeletal Diseases6
Spinal Cord Injuries5
Anorexia Nervosa4
Spinal Cord Diseases4
Bone Resorption3

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.